ipriflavone has been researched along with Intertrochanteric Fractures in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current therapeutic approaches to postmenopausal bone loss or established osteoporosis vary widely among the different regions of the world." | 2.40 | Miscellaneous and experimental agents. ( Reginster, JY, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reginster, JY | 1 |
1 review available for ipriflavone and Intertrochanteric Fractures
| Article | Year |
|---|---|
Miscellaneous and experimental agents.
Topics: Anabolic Agents; Animals; Bone Density; Bone Remodeling; Bone Resorption; Estrogen Antagonists; Estr | 1997 |